查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球整形外科市场 - 2023-2030
市场调查报告书
商品编码
1290386

全球整形外科市场 - 2023-2030

Global Plastic Surgery Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球整形外科市场在2022年达到697亿美元，预计到2030年将见证有利可图的增长，达到1587亿美元。在预测期间（2023-2030年），全球整形外科市场预计将呈现11.1%的复合增长率。越来越多的技术进步和越来越多的新型产品的临床试验正在推动对整形手术的需求。

现在城里最热门的话题是美容或整形手术。通常被认为是安全的最小侵入性程序包括涉及填充物、神经毒素、激光和能量设备的程序。根据美国美容整形外科协会的数据，30多岁的女性更频繁地进行美容手术，30%的吸脂病人在19至34岁之间。

整形外科市场范围包括外科手术类型，如重建外科手术、美容（审美）外科手术和美容微创手术，这增加了整形外科的市场份额。全球整形外科市场正在扩大，其因素包括不断增加的研究和开发，以及各国各主要参与者即将批准的新产品。

市场动态

新产品的不断推出推动了整形外科市场的增长

功能失调或不一致的情况，如先天性损伤或受伤，通过整形手术来解决。为了提高吸引力，采用了整容手术。根据美国美容外科学会的说法，整形手术是用来改善外观或治疗工作不正常的身体部位的。

例如，人们可能会选择做整形手术，以协助修复严重的烧伤，或先天性的损伤，或在乳房切除后重建乳房。整容手术不是出于医疗原因而改善外观，而是侧重于美学考虑。人们可以接受整容手术，如拉皮或鼻子手术，以改变他们的面部或身体的外观。

2023年4月26日，Galderma公司披露，聚左旋乳酸（PLLA-SCA）的注射版Sculptra获得了FDA的批准，可以解决脸颊周围的皱纹以及细纹。Sculptra成功地解决了微笑时的脸颊皱纹，持续时间长达2年，这是它的次要目标，其主要疗效终点是休息时脸颊皱纹减少1级。因此，越来越多的新型产品的推出正在推动整形外科市场的发展。

不断增加的临床试验和研究与开发为制造商创造了有利可图的机会

一些研究人员或研究员对临床研究和基础科学研究的贡献，加速了新型治疗方法的开发，并大大改善了我们对疾病起源和过程的理解。正在进行的几项临床试验取得了积极成果。

在巴黎举行的2023年世界大会国际衰老科学大师班上，致力于提供突破性产品的以客户为中心战略的高性能美容公司Evolus, Inc.介绍了其II期临床研究的中期数据，评估了其旗舰神经毒素产品Jeuveau（prabotulinumtoxinA-xvfs）的 "超强度 "创作，持续时间更长。根据结果，Jeuveau的 "特强 "配方为40U（单位），产生了6个月或26周的持续时间特征。因此，这些因素将推动整形外科市场规模的增长。

与这些手术相关的高风险和并发症将阻碍市场的增长。

血肿是一种可观的、令人不舒服的瘀伤，类似于一个血袋。这种结果发生在1-6%的隆胸手术中；它也可能作为拉皮手术的副作用发生。意外的是，你也可能需要额外的手术来清除血肿中的血液。这个问题几乎总是在手术中发生。

此外，最常见的术后后果之一是感染。乳房手术后的蜂窝组织炎是一种潜在的并发症，可能影响2%至4%的病人。有些感染可能比其他感染更严重，需要静脉注射抗生素。因此，上述因素限制了整形外科市场的增长。

COVID-19影响分析

各个行业的公司的财务健康都受到COVID-19大流行病和全世界众多国家封锁的影响。因此，在COVID-19公共卫生紧急情况期间，美国食品和药物管理局（FDA）发布了指导方针，其中包括帮助赞助商和研究人员的一般注意事项，确保试验参与者的安全，坚持良好的临床实践（GCP），并尽量减少试验完整性的风险。

俄乌战争影响分析

俄罗斯-乌克兰冲突估计对全球整形外科市场的影响不大，因为该地区的主要市场参与者数量较少。然而，在预测期内，原材料进出口的影响预计对全球整形外科市场的增长影响不大。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按外科手术类型分析
  • 按性别分类的摘要
  • 按年龄组分类
  • 按终端用户分类
  • 按地区分类

第4章：动态变化

  • 影响因素
    • 驱动因素
      • 新产品发布的增加
      • 越来越多的临床试验和研究与开发
    • 限制因素
      • 与这些手术相关的高风险和并发症
    • 机会
      • 媒体、社交媒体和时尚行业的影响力不断上升
    • 影响分析

第五章：行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 监管分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情况
    • COVID-19期间的情况
    • COVID-19之后的情况
  • 在COVID-19期间的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结语

第七章：按外科手术类型划分

  • 重建性外科手术
    • 肿瘤切除手术
    • 损伤修复
    • 颌面手术
    • 疤痕修复
    • 手部手术
    • 其他手术
  • 化妆（美学）手术
    • 丰胸
    • 鼻部整形
    • 吸脂术
    • 面部提升
    • 眼睑手术
    • 身体塑形
    • 皮肤再生
    • 其他
  • 微创美容程序
    • A型肉毒杆菌毒素
    • 软组织填充剂
    • 激光换肤
    • 化学换肤
    • 强脉冲光治疗
    • 激光脱皮
    • 其他

第8章：按性别分类

  • 女性
  • 男性

第九章：按年龄组划分

  • 年龄组(13-19岁)
  • 年龄组(20-29岁)
  • 年龄组(30-39岁)
  • 年龄组(40-54岁)
  • 年龄组(55-69岁)
  • 年龄组(70岁以上)

第十章：按终端用户

  • 医院
  • 外科中心/诊所
  • 其他

第十一章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
      • 亚太其他地区
  • 中东和非洲
    • 关键区域的动态

第十二章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併和收购分析

第十三章 ：公司简介

  • Allergan Aesthetics (AbbVie Inc.)
    • 公司概述
    • 产品组合和说明
    • 财务概况
    • 主要发展情况
  • Alma Lasers
  • Cynosure LLC
  • Galderma
  • Bausch Health Companies Inc.
  • Merz Aesthetics
  • Candela Corporation
  • Evolus, Inc.
  • Lumenis Be Ltd.
  • GC Aesthetics

第十四章：附录

简介目录
Product Code: MD443

Market Overview

The Global Plastic Surgery Market reached US$ 69.7 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 158.7 billion by 2030. The global plastic surgery market is expected to exhibit a CAGR of 11.1% during the forecast period (2023-2030). The increasing technological advancements and the growing clinical trials for novel products are driving demand for plastic surgery.

The hottest topics in town right now are cosmetic or plastic procedures. The least invasive procedures that are generally deemed safe include those involving fillers, neurotoxins, lasers, and energy devices. According to the American Society for Aesthetic Plastic Surgery, women in their 30s are having cosmetic operations performed more frequently, and 30% of liposuction patients are between the ages of 19 and 34.

The plastic surgery market scope comprises surgical procedure types such as reconstructive surgical procedures, cosmetic (aesthetic) surgical procedures, and cosmetic minimally-invasive procedures, which has increased the plastic surgery market share. The global market for plastic surgery is expanding as a result of factors including increasing research and development and the upcoming novel product approvals by various key players across countries.

Market Dynamics

The Rising Novel Product Launches Drive the Growth of the Plastic Surgery Market

Instances of dysfunction or inconsistency, such as congenital impairments or injuries, are addressed by plastic surgery. In order to improve the attractiveness, cosmetic surgery is used. According to the American Academy of Cosmetic Surgery, plastic surgery is used to improve the look or treat bodily parts that are not working properly.

One might choose to have plastic surgery, for instance, to assist repair serious burns, or congenital impairments, or to rebuild the breast following a mastectomy. Instead of improving the look for medicinal reasons, cosmetic surgery focuses on aesthetic considerations. People may undergo cosmetic surgery, such as a facelift or nose surgery, to alter the appearance of their face or body.

On April 26, 2023, Galderma disclosed that Sculptra, an injectable version of poly-L-lactic acid (PLLA-SCA), was given FDA approval to address wrinkles as well as fine lines around the cheeks. Sculptra successfully addressed cheek wrinkles during smiling for up to two years, which was its secondary goal, and its main efficacy endpoint of a 1-grade reduction in cheek wrinkles at rest. Hence, the growing number of novel product launches is driving the plastic surgery market.

Rising Clinical Trials and Research and Development Create Lucrative Opportunities for Manufacturers

Contributions to clinical research and fundamental science research from a number of researchers or fellows have accelerated the development of novel treatments and significantly improved our understanding of the origins and course of the disease. Several clinical trials are being conducted resulting in positive outcomes.

At the World Congress International Master Course on Aging Science 2023 in Paris, Evolus, Inc., a performance beauty company with a customer-centric strategy committed to delivering ground-breaking products, presented interim data from its Phase II clinical study evaluating an "extra-strength" creation for a longer duration of Jeuveau (prabotulinumtoxinA-xvfs), its flagship neurotoxin product. According to the results, Jeuveau's "extra-strength" formulation at 40U (units) produced a duration profile of six months or twenty-six weeks. Thus, these factors will drive the growth of the plastic surgery market size.

High Risks and Complications Associated with These Surgeries will Hamper the Growth of the Market.

Hematoma is a sizable, uncomfortable bruise that resembles a bloody pocket. This outcome happens in 1 to 6% of breast augmentation surgeries; it can also happen as a side effect of a facelift. Unexpectedly, you might also require additional surgery to remove the blood from a hematoma. This problem occurs almost always during operations.

Furthermore, one of the most frequent postoperative consequences is infection. Cellulitis following breast surgery is a potential complication that may affect 2 to 4 percent of patients. Some infections could be more serious than others and call for intravenous antibiotics. Hence, the above mentioned factors are limiting the plastic surgery market's growth.

COVID-19 Impact Analysis

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, during the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a low impact on the global plastic surgery market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global plastic surgery market growth over the forecast period.

Segment Analysis

The global plastic surgery market is segmented based on surgical procedure type, gender, age group, end user and region.

Age Group (30-39) Segment Accounts for 38.1% of the Market Share Owing to the Rising Adoption of Plastic Surgery by This Age Group

Historically, everyone between the ages of 18 and 70 was considered a good candidate for plastic surgery. This is due to the fact that most cosmetic operations perform at their peak once the body has reached its full adult size. Males typically attain adult size between ages 15 and 18, whilst girls typically do so between ages 14 and 18.

Up to 1 million Botox treatments are performed annually on people in this age group, making them the most popular cosmetic procedure. Liposuction or breast augmentation comes next. The "Mommy Makeover" is often chosen by women who are finished having children. This entails a thorough range of procedures designed to get the body back to how it was before getting pregnant. They consist of liposuction, breast lift procedures, and stomach tucks.

The 30-45 age group has the highest rate of cosmetic enhancement procedures performed (42.9% annually), making them the highest likely demographic. Anti-aging and body reshaping operations are among the most common for this age range.

Geographical Analysis

North America Accounted for Approximately 43.9% of the Market Share Owing to the Strong Presence of Major Players and Increasing Technological Advancements

Manufacturers have chances to expand their operations in this region because of the rising demand for plastic surgery for advancements in North America. The area has many producers and suppliers, and its rapid economic development has increased the industrial production of plastic surgery, which has increased the demand.

There are many manufacturers and suppliers in North America, and as a result of the region's rapid economic growth, industrial production has expanded, feeding the desire for cosmetic surgery.

The market will grow as new items or technology for surgeries emerge. Rising technological developments, governmental approvals, and the introduction of new products all contribute to growth. Researchers are becoming more aware of their physical appearance, looks, body shape and many more factors related to their appearance, leading to the expansion of the market in this region. These factors show the dominance of North America.

Competitive Landscape

The major global players in the plastic surgery market include: Allergan Aesthetics (AbbVie Inc.), Cynosure LLC, Alma Lasers, Galderma, Merz Aesthetics, Lumenis Be Ltd., Candela Corporation, Bausch Health Companies Inc., Evolus, Inc. and GC Aesthetics among others.

Why Purchase the Report?

  • To visualize the global plastic surgery market segmentation based on surgical procedure type, gender, age group, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of plastic surgery market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global plastic surgery market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Surgical Procedure Type
  • 3.2. Snippet by Gender
  • 3.3. Snippet by Age Group
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Rising Novel Product Launches
      • 4.1.1.2. Rising Clinical Trials and Research and Development
    • 4.1.2. Restraints
      • 4.1.2.1. High Risk and Complications Associated with these Surgeries
    • 4.1.3. Opportunity
      • 4.1.3.1. Rising Influence of Media, Social Media and the Fashion Industry
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Surgical Procedure Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 7.1.2. Market Attractiveness Index, By Surgical Procedure Type
  • 7.2. Reconstructive Surgical Procedure *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Tumor Removal Surgery
    • 7.2.4. Laceration Repair
    • 7.2.5. Maxillofacial Surgery
    • 7.2.6. Scar Revision
    • 7.2.7. Hand Surgery
    • 7.2.8. Others
  • 7.3. Cosmetic (aesthetic) Surgical Procedure
    • 7.3.1. Breast Enhancement
    • 7.3.2. Nose Reshaping
    • 7.3.3. Liposuction
    • 7.3.4. Face Lift
    • 7.3.5. Eye-lid Surgery
    • 7.3.6. Body Contouring
    • 7.3.7. Skin Rejuvenation
    • 7.3.8. Others
  • 7.4. Cosmetic Minimally-Invasive Procedures
    • 7.4.1. Botulinum Toxin Type A
    • 7.4.2. Soft Tissue Filler
    • 7.4.3. Laser Skin Resurfacing
    • 7.4.4. Chemical Peel
    • 7.4.5. Intense Pulsed Light Treatment
    • 7.4.6. Laser Skin Removal
    • 7.4.7. Others

8. By Gender

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 8.1.2. Market Attractiveness Index, By Gender
  • 8.2. Female *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Male

9. By Age Group

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.1.2. Market Attractiveness Index, By Age Group
  • 9.2. Age Group (13-19) *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Age Group (20-29)
  • 9.4. Age Group (30-39)
  • 9.5. Age Group (40-54)
  • 9.6. Age Group (55-69)
  • 9.7. Age Group (70+)

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Surgical Centers/ Clinics
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan

Australia

      • 11.5.7.4. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Procedure Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gender
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Allergan Aesthetics (AbbVie Inc.) *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Alma Lasers
  • 13.3. Cynosure LLC
  • 13.4. Galderma
  • 13.5. Bausch Health Companies Inc.
  • 13.6. Merz Aesthetics
  • 13.7. Candela Corporation
  • 13.8. Evolus, Inc.
  • 13.9. Lumenis Be Ltd.
  • 13.10. GC Aesthetics

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us